Charta Health's AI automates various tasks, such as identifying missed codes, flagging potential billing issues, and ensuring compliance with documentation requirements. The startup focuses on high-volume, low-reimbursement specialties in outpatient settings, differentiating itself from competitors like SmarterDx. With the new funding, Charta plans to expand its sales team and product offerings to address more use cases across different specialties. The company has also hired Dr. Caesar Djavaherian as its chief medical officer to further its mission of creating a versatile platform for patient chart reviews throughout the revenue and care cycle.
Key takeaways:
- Charta Health raised an $8.1 million seed round led by Bain Capital Ventures to expand its AI-driven patient chart review platform.
- The startup was founded by Justin Liu and Scott Morris, who left Rockset after its acquisition by OpenAI, to focus on healthcare technology.
- Charta Health quickly achieved profitability by securing $500,000 in contracts within 60 days through cold emails before launching from stealth in June 2024.
- The company plans to use the seed funding to expand its sales team and product offerings, targeting high-volume, low-reimbursement specialties in outpatient settings.